Yusuf Sherwani is the CEO and Co-Founder of Quit Genius, the world’s first technology-enabled digital clinic for multiple addictions. Together with his colleagues Maroof Ahmed and Sarim Siddiqui, Dr. Sherwani developed a vision for the technology driven addiction treatment platform. Today the company has helped over 750,000 people quit their addictions and improve their lives.

A medical doctor by training and a technology enthusiast at heart, Yusuf is seen as an innovator operating at the intersection of healthcare, technology and design. With a medical degree from Imperial College London, Yusuf has co-authored 12 peer-reviewed studies on behavioral health and substance addictions. He was featured in Forbes’ 30 Under 30 list, 2018 as well as Fast Company’s 100 Most Creative People in Business.

Dr. Jawad N. Saleh is a registered pharmacist who is board-certified in Pharmacotherapy and critical care. He currently serves as Manager of Clinical Services, Critical Care Coordinator and Affiliate Professor for the Pharmacy Department at The Hospital for Special Surgery.

Dr. Saleh received his Bachelors of Science in Pharmacy and his Non traditional post Doctor of Pharmacy degree from St. John’s University in Queens, New York.

Dr. Saleh created and implemented the first pharmacy clinical program at The Hospital for Special Surgery. He has authored and co-authored publications and presentations regarding perioperative impacts of anesthesia in patients. He is a co‑chair for the Pharmacy and Therapeutics, Antimicrobial Stewardship, and sits on the opioid task force. He also serves as a member for several other committees within The Hospital for Surgery.

Dr. Cunningham-Hill is an employee health expert known for his ability to create, identify and implement high-quality workplace health programs including prevention and screening, chronic illness interventions, and mental health and wellbeing initiatives. His broad occupational medicine and public health experience encompasses addressing chronic diseases impacting employers, employees and communities within the context of  social, cultural and racial determinants of health.

Mark has served as the Medical Director for Northeast Business Group on Health since early 2018. Until 2017, he served as Senior Director, Global Solutions Center and Head of Occupational Medicine at Johnson & Johnson, Inc . At J&J, Mark led a team of experts covering occupational medicine, health and wellness, personal energy management, EAP and mental wellbeing, and work-life effectiveness, and supported regional operational groups delivering health services to 135,000 employees in 120 companies. Prior to seven years at J&J, Mark spent 17 years at GlaxoSmithKline in both London and Philadelphia, including as Head of Global Operations, Employee Health Management.

Mark received his MB ChB, Bachelor of Medicine and Bachelor of Surgery at Manchester University in the UK. He is a Fellow of both the American College of Occupational & Environmental Medicine, and the Faculty of Occupational Medicine, London.

Suzette Glasner, Ph.D., VP of Clinical Affairs at Quit Genius, is an Associate Professor at UCLA, in the Department of Psychiatry and Biobehavioral Sciences. Dr. Glasner is a licensed clinical psychologist and scientist whose research focuses on developing and testing digital behavioral treatments for addictions and related psychiatric and medical conditions, and understanding the “key ingredients” of psychotherapy, or how psychotherapy helps people to change their behavior. Three evidence-based treatment approaches that have been the focus of her research studies: Cognitive Behavioral Therapy (CBT), Motivational Enhancement Therapy (MET), and mindfulness based treatments.

Recently she has developed and is testing interventions that deliver these types of treatments using text messaging, social media, and other digital platforms. Dr. Glasner’s award-winning book, The Addiction Recovery Skills Workbook (New Harbinger, 2015), integrates her scientific knowledge about the causes and most effective treatments for addictions, and more than a decade of clinical experience treating individuals and families who are affected by addictions and mental health difficulties. 

Dr. Raymond Hwang is Medical Director at Hinge Health. In addition to his full time role at Hinge Health, Dr. Hwang is a spine surgeon and Assistant Clinical Professor of Orthopedic Surgery at Tufts University School of Medicine, a reviewer for The Spine Journal and serves on the Institutional Review Board and Musculoskeletal Steering Committee at Beth Israel Lahey Health in Massachusetts. He has over 12 years of clinical experience as a spine surgeon and 8 years of experience as an advisor to digital health and medtech companies.

Dr. Hwang earned two engineering degrees from the Massachusetts Institute of Technology, his MD from Harvard Medical School, underwent residency training at the Harvard Combined Orthopedic Surgery Residency Program, and completed his fellowship in Spine Surgery at New England Baptist Hospital. He also holds an MBA from Harvard Business School.

Biography: Audrey Kern, MD, DFASAM Dr. Kern is a diplomate of the American Board of Preventative Medicine, American Board of Addiction Medicine and the American Board of Emergency Medicine. She currently works as Global Medical Director at Pear Therapeutics. She is an expert in Substance Use Disorder and Opioid Use Disorder implementing the development of Prescription Digital Therapeutics as software-based treatments for SUD and OUD. Dr. Kern is an active leader within the American Society of Addiction Medicine. She is Immediate Past President of the Northern New England Society of Addiction Medicine, representing Maine, New Hampshire, and Vermont, and currently serves as ASAM Region III Director with responsibility for the New England region. She has made significant contributions to the field of addiction medicine. As Medical Director for the Addiction Research Center at the Geisel School of Medicine at Dartmouth, Dr. Kern facilitated the design and coordination of NIH and industry-sponsored multi-center trials at Dartmouth Hitchcock Medical Center and other clinic sites in New Hampshire and throughout the country, with a focus on increasing treatment options for alcoholism. During her tenure at the Addiction Treatment Program at Dartmouth, she was a collaborating physician in the Vermont Medication Assisted Treatment Learning Collaborative, helping to pioneer the Hub and Spoke model of addiction health care delivery. As a member of the Perinatal Treatment Program, she provided specialized treatment for pregnant and postpartum women with substance use disorders. She has served in multiple leadership roles including Medical Director for the State of Vermont Department of Corrections, providing leadership and oversight in healthcare services for all inmates in the State of Vermont. As Medical Director for Health Care Resource Centers, methadone treatment programs in New Hampshire, and the Road to a Better Life program, she oversaw the evaluation, coordination, and ongoing care for addictions patients in outpatient-based opioid treatment. Dr. Kern earned her Medical Degree from New York Medical College in Valhalla NY and completed her Emergency Medicine residency at Albany Medical Center in Albany NY. She was the recipient of the Air Force Health Professions Scholarship and served in the United States Air Force from 1985 through 1997. She was as an Emergency Physician at Malcolm Grow Medical Center, Andrew Air Force Base, Washington D.C. and later at Walter Reed Army Hospital, as well as a Clinical Instructor at the Uniformed Service University of Health Services in Bethesda, MD. She received the United States Air Force Medal for Meritorious Service. Dr. Kern was awarded an Osherson Fellowship at the Alonso Center for Psychodynamics at the Fielding Graduate University in Santa Barbara, CA, where she completed a fellowship in 2013 with a study focus on psychodynamic research, theory and clinical application to the field of addictions.

Caroline is the Vice President of State Engagement for Shatterproof's ATLAS team. In this role, Caroline oversees all stakeholder engagement within states implementing Shatterproof’s ATLAS® quality measurement system for addiction treatment facilities. Caroline brings a history of working in harm reduction and advocacy, and a knowledge of addiction and treatment. Prior to coming to Shatterproof, Caroline worked in communications and data analysis at the Viral Hepatitis Program of the NYC Health Department. She is also an experienced HIV/hepatitis C test counselor, and has conducted sessions with over 150 clients in addiction treatment centers and at street-based outreach.

Caroline has a BA in Public Health and French from the University of California at Berkeley and an MPH from the Mailman School of Public Health. She resides in New York City, and is 4 years sober from alcohol.